4.3 Review

MALDI imaging techniques dedicated to drug-distribution studies

Journal

BIOANALYSIS
Volume 3, Issue 12, Pages 1399-1406

Publisher

FUTURE SCI LTD
DOI: 10.4155/BIO.11.88

Keywords

-

Funding

  1. Inserm
  2. Univ Lille Nord de France
  3. Institut Pasteur de Lille
  4. CNRS
  5. EU
  6. Region Nord-Pas de Calais
  7. FEDER [09220019, 09220020 PRESAGE 31510]
  8. ANR [ANR-06-EMPB-033]
  9. PRIM: Pile de Recherche Interdisciplinaire du Medicament)

Ask authors/readers for more resources

Previously, MS was often used to analyze the composition and structure of biological molecules present in solutions. Today, technology developments enable the application of MS for the analysis of localized biomolecules on biological tissue surfaces. This technique is called MS imaging. MALDI imaging MS is a technique whereby thousands of compounds present in a tissue section are detected simultaneously without labeling. Although initially used for the detection of biomolecules such as peptides and proteins, this technology is also used today for drug detection. These characteristics make MS imaging an ideal technology that is perfectly adapted for ADME (absorption, distribution, metabolism and excretion) studies. In fact, this technology facilitates the tracking of one or several administered drugs, as well as the metabolites that result from their assimilations. In this article, we will present the various possibilities that MALDI imaging MS approaches have to offer for the study of drugs and their metabolites using MS, MS/MS, FAST-SRM and MRM modes. In this context, we investigate two studies: the distribution of olanzapine in the kidney and the overall distribution of BDM31343 in mouse whole-body section.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Identification of indole-based activators of insulin degrading enzyme

Nicolas Kraupner, Chau Phi Dinh, Xiaoan Wen, Valerie Landry, Adrien Herledan, Florence Leroux, Damien Bosc, Julie Charton, Clara Maillard, Sandrine Warenghem, Isabelle Duplan, Catherine Piveteau, Nathalie Hennuyer, Bart Staels, Benoit Deprez, Rebecca Deprez-Poulain

Summary: Insulin degrading enzyme (IDE) is linked to the risk of type-2 diabetes (T2D) or Alzheimer's disease (AD). Activating IDE could be a potential therapeutic strategy for AD and also beneficial in diabetes.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Neurosciences

Farnesoid X Receptor Activation in Brain Alters Brown Adipose Tissue Function via the Sympathetic System

Benjamin Deckmyn, Dorothee Domenger, Chloe Blondel, Sarah Ducastel, Emilie Nicolas, Emilie Dorchies, Emilie Caron, Julie Charton, Emmanuelle Vallez, Benoit Deprez, Jean-Sebastien Annicotte, Sophie Lestavel, Anne Tailleux, Christophe Magnan, Bart Staels, Kadiombo Bantubungi

Summary: A study found that activation of the nuclear bile acid receptor in the brain can modify energy homeostasis by affecting the function of brown adipose tissue. Activation of brain FXR decreases the rate-limiting enzyme in catecholamine synthesis, which in turn reduces sympathetic tone. This research sheds new light on the complex control of energy homeostasis by bile acids through FXR.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2022)

Article Cell Biology

The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis

Marion Flipo, Rosangela Frita, Marilyne Bourotte, Maria S. Martinez-Martinez, Markus Boesche, Gary W. Boyle, Geo Derimanov, Gerard Drewes, Pablo Gamallo, Sonja Ghidelli-Disse, Stephanie Gresham, Elena Jimenez, Jaime de Mercado, Esther Perez-Herran, Esther Porras-De Francisco, Joaquin Rullas, Patricia Casado, Florence Leroux, Catherine Piveteau, Mehdi Kiass, Vanessa Mathys, Karine Soetaert, Veronique Megalizzi, Abdalkarim Tanina, Rene Wintjens, Rudy Antoine, Priscille Brodin, Vincent Delorme, Martin Moune, Kamel Djaout, Stephanie Slupek, Christian Kemmer, Marc Gitzinger, Lluis Ballell, Alfonso Mendoza-Losana, Sergio Lociuro, Benoit Deprez, David Barros-Aguirre, Modesto J. Remuinan, Nicolas Willand, Alain R. Baulard

Summary: The compound SMARt751, which interacts with the transcriptional regulator of M. tuberculosis, was found to enhance the efficacy of ethionamide and restore its effectiveness in ethionamide-resistant strains. The compound was also shown to be safe in both in vitro and in vivo tests. A model predicted that a daily dose of 25 mg of SMARt751 would enable a significant reduction in the dose of ethionamide administered while maintaining the same efficacy and reducing side effects.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Chemistry, Medicinal

On the Hunt for Next-Generation Antimicrobial Agents: An Online Symposium Organized Jointly by the French Society for Medicinal Chemistry (Societe de Chimie Therapeutique) and the French Microbiology Society (Societe Francaise de Microbiologie) on 9-10 December 2021

Kevin Antraygues, Nina Compagne, Francesca Ruggieri, Kamel Djaout, Zainab Edoo, Maxime Eveque, Leo Faion, Bruna Gioia, Salia Tangara, Anais Vieira Da Cruz, Baptiste Villemagne, Marion Flipo, Alain Baulard, Nicolas Willand

Summary: This article summarizes the joint autumn symposium organized by the French Society for Medicinal Chemistry and the French Microbiology Society, which attracted over 200 researchers from France and abroad, generating high-level scientific dialogue on the most recent advances in combating antimicrobial resistance.

PHARMACEUTICALS (2022)

Article Chemistry, Medicinal

Design and synthesis of water-soluble prodrugs of rifabutin for intraveneous administration

Kevin Antraygues, Mathieu Maingot, Birgit Schellhorn, Vincent Trebosc, Marc Gitzinger, Benoit Deprez, Olivier Defert, Glenn E. Dale, Marilyne Bourotte, Sergio Lociuro, Nicolas Willand

Summary: In this study, the objective was to design and synthesize rifabutin prodrugs with increased aqueous solubility for intravenous use. Seventeen prodrugs were synthesized using developed synthetic methodologies, and their water solubility, stability in plasma, and antimicrobial activity against A. baumannii were evaluated. A pharmacokinetic release study in CD1 mice demonstrated the successful release of active rifabutin from selected prodrugs.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Analytical

Tumor Distribution by Quantitative Mass Spectrometry Imaging of the Inhibitor of Apoptosis Protein Antagonist Xevinapant in Patients with Resectable Squamous Cell Carcinoma of the Head and Neck (EudraCT Number: 2014-004655-31)

Annick Menetrey, Raphael Legouffe, Amina Haouala, David Bonnel, Elisabeth Rouits, Jacques Bosq, Jonathan Stauber

Summary: As tumors are heterogeneous, investigating drug penetration and concentration in different regions of the tumor is crucial. Quantitative mass spectrometry imaging (QMSI) allows for accurate evaluation of drug efficacy and safety.

ANALYTICAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH Dehydrogenases

Sushovan Dam, Salia Tangara, Claire Hamela, Theo Hattabi, Leo Faion, Paul Carre, Rudy Antoine, Adrien Herledan, Florence Leroux, Catherine Piveteau, Maxime Eveque, Marion Flipo, Benoit Deprez, Laurent Kremer, Nicolas Willand, Baptiste Villemagne, Ruben C. Hartkoorn

Summary: A promising class of compounds called TriSLas has been discovered, showing activity against Mycobacterium tuberculosis by acting as inhibitors of the Ndh-2 enzyme. These compounds increase the NADH/NAD+ ratio and decrease ATP levels in bacteria, providing a new strategy for combating multidrug-resistant strains.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Structure-activity relationships of actively FhuE transported rifabutin derivatives with potent activity against Acinetobacter baumannii

M. Maingot, M. Bourotte, A. C. Vetter, C. B. Schellhorn, K. Antraygues, H. Scherer, M. Gitzinger, C. Kemmer, G. E. Dale, O. Defert, S. Lociuro, M. Bronstrup, N. Willand, V. Trebosc

Summary: Hospital-acquired infections are increasing and becoming a burden on both clinical practice and finances. Acinetobacter baumannii infections are particularly difficult to treat due to their high level of resistance to antibiotics. A recent study found that the antibiotic rifabutin showed potent activity against extensively drug resistant A. baumannii. Further research focused on synthesizing rifabutin analogs and found that their efficacy in A. baumannii was not reflected in other bacteria. The study also identified the structural features necessary for strong accumulation of rifabutin in A. baumannii.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses

Lucile Brier, Haitham Hassan, Xavier Hanoulle, Valerie Landry, Danai Moschidi, Lowiese Desmarets, Yves Rouille, Julie Dumont, Adrien Herledan, Sandrine Warenghem, Catherine Piveteau, Paul Carr, Sarah Ikherbane, Francois-Xavier Cantrelle, Elian Dupre, Jean Dubuisson, Sandrine Belouzard, Florence Leroux, Benoit Deprez, Julie Charton

Summary: Since the end of 2019, the global outbreak of the coronavirus SARS-CoV-2 has caused a significant increase in infections and deaths worldwide. Researchers have identified two proteases, 3CLpro and papain-like protease, encoded by the virus that play a crucial role in the virus lifecycle. Targeting the 3CLpro, which is highly conserved within this viral family, a screening of over 89,000 small molecules led to the discovery of a potent inhibitor of the SARS-CoV-2 3CLpro. The mechanism of inhibition, interaction with the protease, specificity against host proteases, and promising antiviral properties in cells are reported.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Cell Biology

High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry

Clement Philippe Delannoy, Egon Heuson, Adrien Herledan, Frederik Oger, Bryan Thiroux, Mickael Chevalier, Xavier Gromada, Laure Rolland, Philippe Froguel, Benoit Deprez, Sebastien Paul, Jean-Sebastien Annicotte

Summary: Type 2 diabetes is a metabolic disorder affecting over 537 million people worldwide, characterized by loss of pancreatic beta-cell function and insulin resistance. Long-term control of glycemia is challenging, highlighting the need for new drugs and targets to improve beta-cell function and insulin secretion. In this study, a high-throughput screening method using automated cellular assays and mass spectrometry was developed, identifying potential regulators of insulin secretion and synthesis among siRNA and chemical compounds.

CELLS (2023)

Article Chemistry, Medicinal

A Three-Step Process to Isolate Large Quantities of Bioactive Sesquiterpene Lactones from Cichorium intybus L. Roots and Semisynthesis of Chicory STLs Standards

Francesca Ruggieri, Philippe Hance, Bruna Gioia, Alexandre Biela, Pascal Roussel, Jean-Louis Hilbert, Nicolas Willand

Summary: This study describes a novel three-step large-scale extraction and purification method for the simultaneous purification of 11,13-dihydrolactucin (DHLc) and lactucin (Lc) from a chicory genotype rich in these sesquiterpene lactones (STLs) and their glucosyl and oxalyl conjugated forms. The results will facilitate the evaluation of the biological potential of chicory-derived STLs and their semisynthetic analogues.

PHARMACEUTICALS (2023)

Article Chemistry, Medicinal

Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers' Lactamization

Salia Tangara, Leo Faion, Catherine Piveteau, Frederic Capet, Romain Godelier, Marion Michel, Marion Flipo, Benoit Deprez, Nicolas Willand, Baptiste Villemagne

Summary: The concept of privileged structure is an effective method for discovering new biologically active molecules. It refers to a semi-rigid scaffold capable of displaying substituents in multiple spatial directions to provide potent and selective ligands for different biological targets. These structures tend to have improved drug-like properties and are therefore attractive starting points for optimization programs. This article presents a rapid, reliable, and efficient synthesis of novel three-dimensional bio-inspired tricyclic spirolactams and analyzes their drug-like properties.

PHARMACEUTICALS (2023)

Article Chemistry, Medicinal

Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification

Leo Faion, Kamel Djaout, Catalin Pintiala, Catherine Piveteau, Florence Leroux, Alexandre Biela, Stephanie Slupek, Rudy Antoine, Monika Zahorszka, Francois-Xavier Cantrelle, Xavier Hanoulle, Jana Kordulakova, Benoit Deprez, Nicolas Willand, Alain R. Baulard, Marion Flipo

Summary: Mycobacterium tuberculosis causes 1.5 million deaths annually and drug-resistant strains are increasing. Discovery of molecules targeting new M. tuberculosis targets is crucial. Anthranilic acids have been identified as MabA inhibitors, and their structure-activity relationships, binding to MabA, physico-chemical properties, and antimycobacterial activity have been investigated. These compounds affect multiple targets in mycobacterial cells and their antituberculous activity is attributed to their carboxylic acid moiety.

PHARMACEUTICALS (2023)

Article Multidisciplinary Sciences

Occurrence of bisphenols and contribution of edibles liquids conditioned in plastic packaging to the dietary exposure in Cameroon

Olivier Songue Same, Catherine Piveteau, Alexandre Biela, Richard Kamga, Benoit Deprez

Summary: This study aims to assess the levels of bisphenols in sachet water, bagged whisky, crude palm oil, and traditional alcoholic beverages in Cameroon. The research found that the detection limits of bisphenol A, B, and F in water samples were 0.09, 0.10, and 0.09 μg/L, respectively. It was also discovered that one brand of sachet water contained 14.5 μg/L of bisphenol F.

SCIENTIFIC AFRICAN (2023)

Review Chemistry, Medicinal

Antibiotics with novel mode of action as new weapons to fight antimicrobial resistance

Francesca Ruggieri, Nina Compagne, Kevin Antraygues, Maxime Eveque, Marion Flipo, Nicolas Willand

Summary: Antimicrobial resistance (AMR) is a major public health issue causing 5 million deaths per year. To combat this problem, new antibiotics with novel targets or modes of action are needed. Promising compounds such as gepotidacin, zoliflodacin, ibezapolstat, MGB-BP-3, CRS-3123, afabicin, TXA-709, and recently approved lefamulin have shown potential in clinical trials. This review provides information on the chemical synthesis, mode of action, structure-activity relationships, in vitro and in vivo activities, and clinical data of these eight small molecules.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

No Data Available